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Abstract
Background—Heart failure (HF) is an important public health concern particularly among 
persons over 65 years of age. Women and African Americans are critically understudied 
populations that carry a sizeable portion of the HF burden. Limited normative and prognostic data 
exist regarding measures of cardiac structure, diastolic function, and novel measures of systolic 
deformation in older adults living in the community.
Methods and Results—The Atherosclerosis Risk in Communities (ARIC) study is a large, 
predominantly biracial NHLBI-sponsored epidemiologic cohort study. Between 2011 and 2013, 
approximately 6,000 surviving participants, now in their seventh to ninth decade of life, are 
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expected to return for a 5th study visit during which comprehensive 2D, Doppler, tissue Doppler, 
and speckle-tracking echocardiography will be performed uniformly in all cohort clinic visit 
participants. The following objectives will be addressed: (1) to characterize cardiac structural and 
functional abnormalities among the elderly and determine how these differ by gender and race/
ethnicity, (2) determine the relationship between ventricular and vascular abnormalities, and (3) 
prospectively examine the extent to which these non-invasive measures associate with incident 
HF.
Conclusions—We describe the design, imaging acquisition and analysis methods, and quality 
assurance metrics for echocardiography in Visit 5 of the ARIC cohort. A better understanding of 
the differences in cardiac structure and function through the spectrum of HF stages in the elderly 
generally, and between genders and racial/ethnic groups specifically, will deepen our 
understanding of the pathophysiology driving HF progression in these at-risk populations and may 
inform novel prevention or therapeutic strategies.
Introduction
Heart failure (HF) is a progressive disorder afflicting 5 million Americans,1 with over 80% 
of HF hospitalizations occurring in persons over 65 years of age. Up to half of HF cases 
occur in the setting of preserved left ventricular ejection fraction (HFpEF), a syndrome for 
which there are currently no proven therapies.2,3,4 Within the aging population, women and 
African Americans are critically understudied populations.5,6,7 Limited normative data 
exists regarding measures of cardiac structure, diastolic function, and novel measures of 
systolic deformation in the elderly. A better understanding of the differences in cardiac 
structure and function through the spectrum of HF stages in the elderly generally, and 
between genders and racial/ethnic groups specifically, will enhance our understanding of the 
pathophysiology driving HF progression in these populations and may inform novel 
preventive and therapeutic strategies.
The National Heart, Lung, and Blood Institute (NHLBI) Atherosclerosis Risk in 
Communities (ARIC) study was initiated in 1985 in four communities in the U.S. and 
follows 15,792 individuals, 27% of whom are African American.8 Participants are now in 
their seventh to ninth decade of life, an age during which the prevalence of HF increases 
dramatically. Over 6,000 participants are expected to attend the fifth visit cycle (Visit 5) 
occurring from July 2011 to September 2013. The incorporation of comprehensive 
echocardiography (echo) into ARIC therefore presents a unique opportunity to examine 
cardiac structure and function in a biracial elderly cohort, and to investigate alterations in 
cardiac structure and function across the spectrum of HF stages, their relationship to clinical 
outcomes, and whether they vary in these critically understudied populations.
We describe the design, imaging acquisition and analysis methods, and quality assurance 
metrics for echocardiography in Visit 5 of the ARIC cohort.
Methods
The ARIC study design and methods have been previous described in detail.8 ARIC is a 
prospective epidemiologic cohort study which, between 1987 and 1989, enrolled 15,792 
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middle-aged subjects in 4 U.S. communities: Forsyth County, NC, Jackson, MS, suburban 
Minneapolis, MN, and Washington County, MD. Cohort participants underwent four exam 
visits between 1987 and 1998. Between 2011 and 2013, approximately 6,000 surviving 
participants are expected to return for a 5th study visit. ARIC participants undergo 
surveillance for cardiovascular events including HF, incident coronary heart disease events, 
and all-cause mortality as previously described in detail.9,10 Incident HF is based on ARIC 
Mortality and Morbidity Classification Committee adjudicated HF hospitalization 
(performed since 2005), including data on LVEF assessment during hospitalization, as 
previously published.11
Visit 5 is the first examination in which echo is being performed in all four ARIC field 
centers. The echo imaging and analysis protocol, sonographer training and certification 
process, quality assurance plan, and statistical methodologies were initially designed by 
investigators at the Echocardiography Reading Center (ERC; Brigham and Women’s 
Hospital, Boston, MA) in response to a Request for Proposals from the NHLBI. These 
methods were then modified, finalized, and implemented in collaboration with investigators 
from the ARIC Field Centers, Coordinating Center, and Steering Committee.
Echo in ARIC Visit 5 is designed to address three specific aims: The first is to characterize 
the abnormalities of cardiac structure and function in a community-based sample of elderly 
individuals and assess how these abnormalities vary by gender and race/ethnicity. The study 
utilizes standard and novel echo techniques to characterize five specific domains of cardiac 
performance: (a) left ventricular (LV) structure and geometry, (b) LV systolic function 
assessed by novel 2D speckle-tracking based deformation imaging, (c) LV diastolic 
function, (e) left atrial (LA) structure, and (f) pulmonary vascular resistance and systolic 
pressure, and right ventricular (RV) function. These data will be used to define the 
population distribution of these measures and to determine their relationship with 
cardiovascular risk factors, including hypertension, diabetes, coronary disease, renal 
insufficiency, and prognostically relevant biomarkers such as NT-proBNP and high 
sensitivity troponin T. The second aim is to characterize the cross-sectional relationship of 
ventricular with vascular abnormalities in the community setting and determine how these 
associations vary by gender and race/ethnicity. The study will investigate ventricular-arterial 
coupling in addition to the association of cardiac structure and function with arterial stiffness 
assessed by contemporaneous carotid-femoral pulse wave velocity, aortic morphology, and 
ankle-brachial index. The third aim is to prospectively examine the extent to which these 
non-invasive measures associate with incident HF and determine the degree to which these 
associations vary by gender and race/ethnicity. This study will assess the incremental value 
of LV deformation, pulmonary pressure and vascular resistance, and RV function in 
predicting risk of HF beyond LV structure and conventional measures of systolic and 
diastolic function. In accomplishing these objectives, this study is developing an echo 
imaging database that will facilitate future investigations to: 1) compare these echo 
measures both to studies previously performed in the ARIC Jackson cohort (1993–1995) and 
to studies in complementary cohorts; and 2) evaluate novel strain-based and 3D measures of 
cardiac function, including the LA and RV.
Shah et al. Page 3














Development of the imaging and analysis protocol, Field Center Echocardiography Manual 
of Operations, Reading Center Manual of Operations, hiring of Field Center sonographers, 
and purchase of uniform Field Center echo imaging equipment occurred between November 
2010 and April 2011 (Figure 1). Training and certification of sonographers occurred in April 
2011. Pilot testing occurred from May to June 2011, followed by the initiation of ARIC 
Visit 5 in June 2011, which is expected to continue through September 2013.
Data Recording and Transmission
All echos are performed using dedicated Philips iE33 Ultrasound systems with Vision 2011 
and the X5-1 xMatrix transducer for 2D, Doppler, and 3D data acquisition, purchased 
specifically for use in the ARIC study. Machines at all Field Centers were set to acquisition 
defaults as detailed in Table 1. Image acquisition was performed using a pre-programmed 
acquisition protocol which guided sonographers through each protocol required view as 
outlined in Table 2. All studies were acquired and stored digitally on a local PACs and 
transferred from Field Centers to a secure server at the ERC (Brigham and Women’s 
Hospital, Boston, MA) same day via a dedicated VPN connection, along with an electronic 
case report form containing information on demographics, anthropomorphic measures, and 
blood pressure at time of echo.
Image Acquisition Protocol and Techniques
The ARIC echocardiography imaging protocol is detailed in Table 2. Participant blood 
pressure is taken within 30 minutes of starting the echo and after the subject has been resting 
for 5 minutes. Electrocardiographic leads are placed on the subject prior to imaging and 
sonographers are instructed to ensure an adequate ECG signal with clearly identifiable QRS 
complex throughout the exam duration. All echos are obtained in a manner most consistent 
with good subject care.
For patients in sinus rhythm, at least three full cardiac cycles are recorded for each view, 
with recording beginning once the view is optimized. For subjects in atrial fibrillation, at 
least one 5 second acquisition per view is recorded. Sonographers did not record any 
measurements on the images, as all measurements are performed centrally at the ERC.
For 2D imaging, sonographers were instructed to continuously optimize both imaging depth 
and sector width to maintain a frame rate of 50–80 frames per second. As optimal 
visualization of endocardial borders is essential for quantitative analysis, sonographers were 
instructed to increase 2D gain if necessary to optimally demonstrate LV endocardial borders, 
particularly in the apical views, and to use harmonic imaging except in the unusual situation 
where this worsens endocardial border definition.
For all color Doppler imaging, the color Doppler Nyquist limit is set at 64 cm/sec. Color 
Doppler gain is set at a level just below the level at which random background noise is seen. 
Sonographers were proscribed from altering the color Doppler gain and the Nyquist limit 
from the ARIC protocol defaults. Color Doppler variance display is not utilized.
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For spectral Doppler, sonographers ensure that the ultrasound beam is optimally aligned 
parallel to the direction of the blood flow of interest, and demonstrates a clear onset and end 
of flow. Sonographers continuously optimize the baseline shift and velocity range such that 
the spectral envelope occupies approximately three-fourths of the display. All spectral 
Doppler acquisitions are performed with the following ARIC protocol defaults: (1) sweep 
speed 100 cm/sec, and (2) sample volume length 3mm [for pulsed wave Doppler].
For tissue Doppler imaging (TDI), the tissue Doppler sample volume is placed at the level of 
annulus (mitral or tricuspid depending on the view being obtained) and the baseline shift and 
velocity range optimized. All TDI is acquired with the following ARIC protocol defaults: 
(1) sweep speed 100 cm/sec, (2) sample volume length 5mm, and (3) filter setting of 100 
Hz.
For 3D echo, a full-volume electrocardiogram (ECG)-gated 3D dataset of both the LV/LA 
and RV/RA is acquired from the apical position with the matrix array 3D transducer. During 
breath-hold, depth and sector width are adjusted to optimize spatial and temporal resolution 
within the sample volume. In the tissue harmonic mode, 4 wedge-shaped sub-volumes are 
acquired over 4 consecutive cardiac cycles and automatically integrated into a wide-angle 
pyramidal dataset with the highest frame rate achievable (20–26 Hz in our study).
Measurement Protocol
All conventional echo measures are performed using a proprietary validated echo analysis 
software, which directly inputs and tracks measurement data into an automated database 
system, with each measurement linked to a JPEG image of the associated tracing for later 
review by cardiologist over-readers. Myocardial deformation analysis is performed utilizing 
the TomTec Cardiac Performance Analysis package (Munich, Germany), a validated vendor 
independent software package for echo speckle tracking analyses of strain and strain rate. 
All quantitative measures are performed in a modular fashion by 4 analysts (Figure 2), such 
that for any given measure the same analyst performs that measure for all echo studies. All 
measurements are performed in triplicate.
As outlined in Table 3, LV dimensions, wall thickness, anterior-posterior left atrial (LA) 
dimension, and outflow tract diameter are measured from the parasternal long axis view 
according to the recommendations of the American Society of Echocardiography (ASE).12 
LV mass is calculated from LV linear dimensions and indexed to body surface area as 
recommended by ASE guidelines. LV hypertrophy (LVH) is defined as LV mass indexed to 
body surface area (LV mass index, LVMi) >115 g/m2 in men or >95 g/m2 in women. 
Relative wall thickness (RWT) was calculated from LV end-diastolic dimension and 
posterior wall thickness. LV volumes are calculated by the modified Simpson’s method 
using the apical 4 and 2 chamber views, and LV ejection fraction (LVEF) is derived from 
volumes in the standard manner.
LA volume was measured by the method of discs using apical 4- and 2-chamber views at an 
end-systolic frame preceding mitral valve opening, and was indexed to body surface area to 
derive LA volume index (LAVi). Mitral regurgitation (MR) is categorized by tracing the jet 
area (obtained with color Doppler imaging) occupying the left atrium in 4- and 2-chamber 
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views and was expressed as a proportion of LA area. The presence of an eccentric jet raised 
the grade of MR by 1 degree. Early transmitral velocity (E wave) was measured by pulsed 
wave Doppler from the apical 4-chamber view with the sample volume positioned at the tip 
of the mitral leaflets. Peak lateral and septal mitral annular relaxation velocities (e′) were 
assessed using TDI. E/e′ ratio was calculated as E wave divided by e′.13
In accordance with ASE guidelines,14 RV function was assessed using the tricuspid annular 
peak systolic velocity (TA s’) measured from the lateral tricuspid annulus, and RV fractional 
area change (RVFAC) calculated as the percent change in cavity area from end-diastolic to 
end-systolic tracings of the RV cavity in the apical 4 chamber view. From the parasternal 
short axis view at the level of the aortic valve, the RV outflow tract time velocity integral 
(RVOT VTI) by pulse Doppler is measured as a correlate of RV stroke volume. Peak 
tricuspid regurgitation (TR) velocity is measured and peak RV-to-right atrial systolic 
gradient calculated as 4·(peak TR velocity)2. Pulmonary vascular resistance is calculated 
using the RVOT VTI/TR velocity ratio, as previously published.15
To assess ventricular-arterial coupling, effective arterial elastance (EaI) is being estimated as 
end-systolic pressure divided by stroke volume, determined using the Simpson’s method of 
discs and indexed to body surface area. LV end-systolic pressure is estimated as 0.9 
multiplied by brachial systolic blood pressure performed at the time of echocardiography.16 
LV end-systolic elastance (EesI) is estimated from the modified single-beat method using 
brachial pressures, stroke volume calculated from LV volumes, pre-ejection and total 
ejection times measured from spectral Doppler tracings, LVEF, and an estimated normalized 
ventricular elastance at arterial end diastole, and is indexed to body surface area.17
Deformation analysis is performed using the TomTec Cardiac Performance Analysis 
package, which has been validated against MRI and sono-micrometry.18,19 Analysis is 
performed on 2D images acquired at a frame rate of 50–80 frames per second. Longitudinal 
strain (LS) is measured by tracing the endocardial borders in the apical 4-chamber and 2-
chamber views, while circumferential (CS) and radial strain (RS) are measured by tracing 
endocardial and epicardial borders from the parasternal short axis view at the level of the 
mid-papillary muscle. Studies with inadequate image quality are not measured and are 
defined as studies with more than 1 segment dropout or significant foreshortening of the LV. 
The endocardial border is traced at an end-diastolic frame in apical views, where end-
diastole is defined as the frame after mitral valve closure, and at end-systole in short axis 
views. The software tracks speckles along the endocardial and epicardial borders throughout 
the cardiac cycle. Peak longitudinal and circumferential strain and strain rate are computed 
automatically, generating regional data from 6 segments and an average value for each view.
Analysis of 3D datasets will be performed using the TomTec software (Image-Arena VA, 
TomTec, Corp). Epicardial and endocardial borders at end-diastole are automatically traced 
by the software with minimal manual adjustment. LVEDV, LVESV, LVEF, global 3D 
strains, 3D longitudinal, circumferential, and radial strains are computed automatically.
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All echocardiograms are over-read by a Board Certified staff cardiologist at the Brigham 
and Women’s Hospital with COCATS Level 3 advanced training in echocardiography 
and/or ASE Board Certification in Comprehensive Adult Echocardiography. Over-readers 
are presented with the following key quantitative measurements made by technicians: LV 
end-diastolic dimension, wall thickness, end-diastolic volume, end-systolic volume, LVEF, 
LAVi, RVFAC, MR jet area-to left atrial area ratio, aortic valve peak antegrade velocity, 
and TR velocity. Over-readers review echocardiograms to confirm the accuracy of these 
measurements and to identify clinically important findings not otherwise represented by the 
technical measurements. Such clinically important findings include significant aortic 
insufficiency, mitral stenosis, pulmonary hypertension, or right ventricular enlargement. 
Over-readers must approve analysis for each study prior to study data being finalized for 
transfer to the ARIC Coordinating Center.
Following data transfer, the ARIC Coordinating Center incorporates LVEF, LV end-
diastolic dimension, and LV wall thickness into a summary letter of Visit 5 test results, 
which is sent to participants as a courtesy. Additional clinically relevant findings identified 
by ERC over-readers are also reported in this letter.
Training and Certification
In April 2011, all ARIC Field Center sonographers underwent an intensive 3 day centralized 
training at the Brigham and Women’s Hospital, consisting of both: (1) didactic sessions 
reviewing the exam protocol, machine presets, required views, and image acquisition/
optimization tips, and (2) hands-on sessions led by an ERC senior sonographer to facilitate 
image optimization.
In the weeks following training, all sonographers were required to perform and submit two 
complete echo studies in accordance with the study protocol specifications and using study 
echo equipment. Studies were reviewed at the ERC and scrutinized for adherence to 
protocol, acquisition of all required views, and image quality. Following submission of two 
adequate echo studies, sonographers were certified. Three new sonographers started during 
the Visit 5 period after initial study start-up. All underwent the certification process outlined 
above.
Quality Assurance Procedures
For every study performed during the Visit 5 period, sonographers receive directed feedback 
from the ERC regarding study quality, typically within a week of study performance, 
including an itemized list of study deficits if present. In addition to over-reading of all 
studies by staff cardiologists, the ERC assesses measurement variability at regular intervals 
during the study period. Given the ERC modular analysis model, whereby each ERC 
technician is responsible for specific quantitative measures for each echo, the focus of the 
ERC quality assurance procedures is intra-observer variability and temporal drift. Analysts 
must re-analyze previously completed studies, blinded to participant ID and prior 
measurement values. Variability is assessed at 4 month intervals in both: (1) a set of 20 
studies blindly repeated throughout study period for assessment of temporal drift, and (2) a 
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set of 20 random ARIC studies newly selected at each reproducibility cycle. Overall, 
reproducibility assessments will be performed in an estimated 160 unique studies during the 
Visit 5 period.
Reproducibility metrics for key conventional echo measures from the first 3 assessment 
cycles are provided in Table 4. Analysis of cardiac deformation started approximately 9 
months after conventional 2D and Doppler analysis. Findings from the first strain 
reproducibility assessment demonstrated the following: mean ± standard deviation of the 
difference between measurements of 0.2±1.4% for LS in the apical 4 chamber view, 
0.8±1.2% for LS in the apical 2 chamber view, and 1.7±2.8% for CS; coefficient of variation 
(CV) of 7.7% for LS in the apical 4 chamber view, 6.4% for LS in the apical 2 chamber 
view, and 9.7% for CS.
Statistical Approach and Power Considerations
Standard descriptive statistics will be used to define the population distribution of 
echocardiographic measures. The association of these measures with demographic, clinical, 
and physiologic variables will be assessed using correlation analysis, in addition to 
univariable and multivariable regression. The relationship between cardiac structural and 
functional measures and clinical outcomes will be evaluated using univariable and 
multivariable Cox proportional hazard regression models. Intercurrent events expected to 
alter cardiac structure and function, including definite or probable MI or coronary 
revascularization, will be introduced into Cox proportional hazard regression models as 
time-varying covariates. Additional sensitivity analyses will exclude individuals with 
intercurrent events. Stratified analyses will also be performed by gender and race/ethnicity. 
Effect modification by gender or race/ethnicity will be assessed by introducing interaction 
terms into multivariable models. Analyses will be performed with echocardiographic 
measures modeled as continuous variables with non-linear relationships assessed using 
polynomial terms, as quartiles, and as dichotomous. Model assumptions will be assessed 
using standard techniques.
This study will be one of the largest and most comprehensive echocardiographic datasets in 
an elderly cohort, including elderly women and African Americans. Multiple analyses are 
therefore expected, including descriptive analyses to establish normative values, cross-
sectional association studies to investigate predictors and correlates, and time-to-event 
analyses to assess the relationship to clinical outcomes. Echocardiographic measures are 
inter-correlated, and for statistical purposes do not represent completely independent 
hypotheses. No unitary approach to adjustment for multiple testing is pre-specified for all 
anticipated analyses. Instead, the most appropriate approach will be selected for each 
analysis. Similarly, study power will vary broadly between analyses, as will power to detect 
effect modification by gender or race/ethnicity. We anticipate the study power to be most 
limited for the prospective association of measures of cardiac structure and function with 
incident cardiovascular events, including incident HF. Power calculations for these time to 
event analyses were performed for log-rank tests with significance defined as a two-sided p-
value <0.05, and with echocardiography measures modeled dichotomously, using the 
stpower function in Stata 11. ARIC participants will be followed for incident HF events over 
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5 years of follow-up after Visit 5 (through 2017). Based on observed HF incidence in ARIC 
from 2004 – 2008, we estimate an incidence of HF of ~2%/year, with approximately 726 
incident cases of HF during follow-up. This estimate is conservative, as events will also 
accumulate during the 2.5 year period when Visit 5 is ongoing. Assuming a study population 
of approximately 6,000, our projected power based on effect size, prevalence of ‘abnormal’, 
and projected follow-up time is shown in the Table 5. These power estimates are 
conservative as modeling echocardiographic measures as continuous variables (as opposed 
to dichotomous) will likely result in greater power. Power estimates for interaction testing 
by gender and race/ethnicity are provided in the Supplemental Data section.
Comparison of ARIC to Other Population-Based Echocardiographic Studies
Compared to existing population-based echo studies, the ARIC echo study will be one of the 
largest (Table 6).20–33 ARIC is also studying one of the most elderly cohorts with a sizeable 
proportion of African-American participants. The ARIC echo study will be uniquely 
comprehensive, utilizing 2D, 3D, Doppler, tissue Doppler, and speckle tracking 
echocardiography to quantify LV structure and function, ventricular deformation, pulmonary 
arterial pressure and vascular resistance, and RV function.
Conclusions
The ARIC echo study will uniformly acquire and measure cardiac structure and function, 
including novel assessments of myocardial deformation, in approximately 6,000 elderly 
cohort participants. Comprehensive echo in this large, well-phenotyped, elderly, biracial 
cohort offers the unique opportunity for an integrated characterization of the perturbations of 
cardiac structure and function, and of ventricular-arterial interactions, in advanced age. This 
comprehensive cardiovascular assessment is necessary to: (1) define age-specific normative 
values for echo measures of cardiac structure and function in the elderly; (2) further 
elucidate the mechanisms by which HF risk factors, such as hypertension, diabetes, obesity, 
and renal insufficiency, influence cardiac structure and function – and HF risk – in older 
adults; and (3) determine how these age and risk factor related perturbations differ in 
critically understudied populations, namely women and African Americans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Outline of the overall design of the ARIC echo study. *End date for Visit 5 is approximate. 
FC – field center.
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Illustration of the modular analysis approach employed in the ARIC echo study and the 
timing of serial analyst variability testing during the Visit 5 period. *End date for Visit 5 is 
approximate.
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Table 1
iE33 Ultrasound system image acquisition defaults for all ARIC echo studies.
2D images Color Doppler Spectral Doppler
H pen Gain 65 Compress 4
Xres ON Map 4 Reject 4
Elevation compounding ON Smoothing 3 Speed 100 mm/sec
Chroma 1 Persistence OFF
Gray scale 4
Persistence low
Re-speed in the midline
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Table 2
ARIC echo imaging protocol required views.
A. Brachial Blood pressure
B. Parasternal Position
• Ensure that BP obtained within 30 min of the echo examination
☑ Parasternal long axis • 2D imaging (at deep depth)
• 2D imaging (at shallow depth)
• Color Doppler of the mitral and aortic valves
 ☑ Parasternal short axis – Aortic valve level • 2D imaging of AV
• Color Doppler of AV
• 2D imaging of right ventricular outflow tract
• Color Doppler of right ventricular outflow tract
• PW and CW Doppler of the RVOT
☑ Parasternal short axis – Mitral valve level • 2D imaging
☑ Parasternal short axis – Papillary muscle level • 2D imaging
• M-mode
☑ Parasternal short axis – LV apex • 2D imaging
C. Apical Position
☑ Apical 4 chamber view • 2D imaging
• 2D imaging, focused/zoomed on LV
• 2D imaging, focused on LA
• Color Doppler of mitral valve/LA
• PW Doppler of mitral flow
• TDI of septal and lateral mitral annulus
• omniplane to 2-chamber view (2D imaging)
• omniplane to 3-chamber view (2D imaging)
• 3D full volume acquisition of LV
• 3D full volume acquisition of RV
☑ Apical 4 chamber – focused on the RV • 2D imaging
• Color Doppler of tricuspid valve/RA
• CW Doppler of tricuspid regurgitation
• TDI of lateral tricuspid annulus
☑ Apical 5 chamber view • 2D imaging
• Color Doppler of left ventricular outflow tract
• Pulse wave of LVOT flow
• CW of transaortic flow
☑ Apical 2 chamber view • 2D imaging focused/zoomed on LV
• 2D imaging focused on LA
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C. Apical Position
• Color Doppler MV/LA
☑ Apical 3 chamber view • 2D imaging
D. Subcostal View
☑ Inferior vena cava • 2D imaging (5 second acquisition)
BP – blood pressure; AV – aortic valve; PW – pulse wave; CW – continuous wave; RVOT – right ventricular outflow tract; LV – left ventricle; LA 
– left atrium; RV – right ventricle; RA – right atrium; LVOT – left ventricular outflow tract.
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Table 3
ARIC echo primary and derived measures.
Primary measures Derived measures
LV structure LV end-diastolic dimension (PLAX)
LV end-systolic dimension (PLAX)
LV wall thickness (PLAX)
LV end-diastolic volume (A4C, A2C)
LV end-systolic volume (A4C, A2C)
LV end-diastolic volume (3D)
LV end-systolic volume (3D)
LV mass (g) = 0.8*{1.04*[(LVEDD+ASWT+PWT)3 –
(LVEDD)3]}+0.6
LV mass index (g/m2) = LV mass/BSA
LV relative wall thickness = (2*PWT)/LVEDD
Mean LV wall thickness (cm) = (PWT+ASWT)/2
LV systolic function TDI s’ (A4C)
Longitudinal S, SR (A4C, A2C)
Radial & circumferential S, SR (PSAX)
Ejection fraction (%) = 100 *(LVEDV – LVESV)/LVEDV
Ejection fraction (by 3D)
LV dyssynchrony Standard deviation in time to peak longitudinal strain (12 
segemnts), radial strain (6 segments), and circumferential strain 
(6 segments)
LV diastolic function Mitral annular TDI e′ (A4C)
E wave, A wave, DT (A4C)
E/A ratio = E wave/A wave
E/E′ ratio = E wave/TDI e′
LV-arterial interaction Arterial elastance (EA) = (SBP × 0.9)/SV
LV end-systolic elastance (EES) = [DBP – (ENd(est) x SBP X 
0.9)]/[SV/BSA x ENd(est)], where:
ENd(est) = 0.0275 – 0.165 × EF + 0.3656 × (DBP/SBP) + 0.515 
× ENd(avg), and ENd(avg) = Σai x tNdi where tNd = R→onset/
R→end, and ai are (0.35695, −7.2266, 74.249, −307.39, 
684.54, − 856.92, 571.95, −159.1) for i = 0 to 7
EA/EES ratio = EA/EES
Valvular Function Aortic Valve: LVOT VTI, AV peak 
velocity, mean gradient, and VTI (A5C)
Mitral Valve: MR jet area (A4C)
MR jet area-to-LA area ratio = MR jet area (cm2)/Left atrial 
area (cm2)*100
LA structure & function LA A-P dimension (PLAX)
LA volume (A4C, A2C)
LA area (A4C, A2C)
LA volume index (ml/m2) = LA volume/BSA
Pulmonary vascular measures TR velocity (A4C)
RVOT VTI (PSAX)
Peak RV-RA gradient (mmHg) = 4*(peak TR velocity)2
Pulmonary Vascular Resistance (Wood Units) = 0.1618 + 
10.006 * (peak TR velocity/RVOT VTI)
RV systolic function RV end-diastolic area (A4C)
RV end-systolic area (A4C)
Tricuspid annular TDI s’ (A4C)
RV fractional area change (%) = 100*(RVEDA – RVESA)/
RVEDA
PLAX – parasternal long axis view; A4C – apical 4-chamber view; apical 2-chamber view; PSAX – parasternal short axis view; LVEDD – LV 
end-diastolic dimension; ASWT – anteroseptal wall thickness; PWT – posterior wall thickness; BSA – body surface area; TDI – tissue Doppler 
imaging; s′ – peak systolic mitral annular velocity; S – strain; SR – strain rate; LVEDV – LV end-diastolic volume; LVESV – LV end-systolic 
volume; e′ – peak early diastolic mitral annular velocity; DT – deceleration time; SBP – systolic blood pressure; DBP – diastolic blood pressure; 
SV – stroke volume; LVOT – LV outflow tract; VTI – velocity-time integral; AV – aortic valve; MR – mitral regurgitation; A-P – anterior-
posterior; RVOT – RV outflow tract; TR – tricuspid regurgitation; RVEDA – RV end-diastolic area; RVESA – RV end-systolic area. Speckle-
tracking analysis was performed on images acquired at 50–80 frames per second.
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Table 5
Power estimates for time-to-event analysis by log-rank test of the association of echocardiographic measures 
of cardiac structure and function with incident HF at 5 year follow-up at a significance level defined as a two-
sided p value of <0.05. These power estimates model echocardiographic measures as dichotomous variables 
and assume approximately 726 incident cases of HF during follow-up, based on an estimated incidence of HF 





17% 0.50 0.83 0.97
29% 0.65 0.94 0.99
38% 0.71 0.96 0.99
45% 0.72 0.96 0.99
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